T2 Biosystems, Inc. IPO Research Information

T2 Biosystems, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on T2 Biosystems, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
T2 Biosystems, Inc.	TTOO - NASDAQ	$15.00-$17.00	$11.00	$15.95	5.2 million	8/7/2014
Underwriter(s): Goldman Sachs & Co., Morgan Stanley
Co-Manager(s): Leerink Partners, Janney Montgomery Scott
Industry: Health Care
Filing(s): Filed 2014-07-02 Terms Added 2014-07-28

T2 Biosystems, Inc. Quote & Chart - Click for current quote - TTOO

About T2 Biosystems, Inc. (adapted from T2 Biosystems, Inc. prospectus):
They are an in vitro diagnostics company that has developed an innovative and proprietary technology platform that offers a rapid, sensitive and simple alternative to existing diagnostic methodologies.

This description is adapted from T2 Biosystems, Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as T2 Biosystems, Inc. "TTOO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.